Heidelberg Pharma AG (ETR:HPHA)
Germany flag Germany · Delayed Price · Currency is EUR
2.540
-0.060 (-2.31%)
Aug 5, 2026, 5:35 PM CET

Heidelberg Pharma AG Cash Flow Statement

Millions EUR. Fiscal year is Dec - Nov.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Net Income
-33.1-42.28-19.38-20.35-19.7-26.14
Depreciation & Amortization
0.530.830.840.820.680.75
Other Amortization
0.020.020.040.050.080.06
Loss (Gain) From Sale of Assets
-0.090.010.060.07-0.010.01
Asset Writedown & Restructuring Costs
4.974.97----
Loss (Gain) From Sale of Investments
----4.75--
Loss (Gain) on Equity Investments
-----0.01
Stock-Based Compensation
-0.020.110.910.960.550.69
Other Operating Activities
6.414.59-0.06-0.12-0.330.46
Change in Accounts Receivable
-0.110.280.690.12-0.080.17
Change in Inventory
-2.1-3.29-1.33-5.9-3.84-0.52
Change in Accounts Payable
-0.591.62-2.332.122.15-1.91
Change in Unearned Revenue
1.12-1.18-4.93-4.7910.410.26
Change in Other Net Operating Assets
-1.842.71-4.1-1.911.24-0.45
Operating Cash Flow
-24.8-31.6-29.59-33.67-8.86-26.61
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Capital Expenditures
-0.06-0.13-0.46-0.94-0.58-1.24
Sale of Property, Plant & Equipment
0.7-0.030.030.02-
Sale (Purchase) of Intangibles
-0-0.01-0.02-0.02-0.03-0.15
Investment in Securities
---6.78--0.01
Other Investing Activities
-0-0-0--
Investing Cash Flow
0.63-0.14-0.455.85-0.6-1.4

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Short-Term Debt Issued
----510
Total Debt Issued
----510
Short-Term Debt Repaid
---5-10--
Long-Term Debt Repaid
--0.13-0.11-0.11-0.09-0.1
Total Debt Repaid
-0.12-0.13-5.11-10.11-0.09-0.1
Net Debt Issued (Repaid)
-0.12-0.13-5.11-10.114.919.9
Issuance of Common Stock
18.7818.7822.760.0679.9120.02
Other Financing Activities
-1.64-0.3-1.58-0-0.82-0.75
Financing Cash Flow
17.0118.3516.08-10.058429.17

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Foreign Exchange Rate Adjustments
-1.16-1.06-0.06-0.010.650
Miscellaneous Cash Flow Adjustments
--00---
Net Cash Flow
-8.32-14.45-14.02-37.8975.191.16

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Free Cash Flow
-24.86-31.73-30.04-34.61-9.45-27.85
Free Cash Flow Growth
------
Free Cash Flow Margin
-333.95%-2177.08%-438.64%-351.07%-51.03%-1369.57%
Free Cash Flow Per Share
-0.53-0.68-0.65-0.74-0.25-0.86
Levered Free Cash Flow
-18.87-21.74-23.51-21.5-7.26-18.84
Unlevered Free Cash Flow
-18.87-21.74-23.42-21.02-6.74-18.53

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Cash Interest Paid
0.010.010.790.910.530.03
Change in Working Capital
-3.520.14-11.99-10.369.88-2.45